ACET

ACETO Reports Fiscal 2013 First Quarter Results

[at noodls] – FISCAL 2013 FIRST QUARTER HIGHLIGHTS (Comparisons to FY 2012 Q1): Net sales increased 10.3% to $111.7 million, from $101.3 million Gross profit increased 16.1% to $21.5 million, from $18.5 million Net … moreView todays social media effects on ACETView the latest stocks trending across Twitter. Click to view dashboard […]

ACETO Subsidiary, Rising Pharmaceuticals, Announces the Signing of Their First Agreement to Market an Authorized Generic Drug (Parnate(R) Product) With Covis Pharma S.a.r.l.

[at noodls] – ACETO Subsidiary, Rising Pharmaceuticals, Announces the Signing of Their First Agreement to Market an Authorized Generic Drug (Parnate(R) Product) With Covis Pharma S.a.r.l….This is an abstract of the … moreView todays social media effects on ACETView the latest stocks trending across Twitter. Click to view dashboard […]

ACETO Corporation Schedules Fiscal 2013 First Quarter Financial Results News Release and Conference Call

[at noodls] – ACETO Corporation Schedules Fiscal 2013 First Quarter Financial Results News Release and Conference Call PORT WASHINGTON, N.Y., Oct. 25, 2012 (GLOBE NEWSWIRE) — ACETO Corporation (Nasdaq:ACET), a global … moreView todays social media effects on ACETView the latest stocks trending across Twitter. Click to view dashboard […]

ACETO to Present at the Singular Research 7th Annual Best of the Uncovereds

[at noodls] – PORT WASHINGTON, N.Y., Oct. 23, 2012 (GLOBE NEWSWIRE) — ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Intermediates … moreView todays social media effects on ACETView the latest stocks trending across Twitter. Click to view dashboard […]